Diagnostic ECG
Clinical Insights

Conversations at the frontier to enable physicians to maximize the power of the ECG.

  • FEATURED ARTICLE

    When Should You Take an ECG for a COVID-19 Patient?

Diagnostic ECG - Articles

Diagnostic ECG - Videos

  • Diagnosing STEMI in the presence of COVID-19

    The COVID-19 pandemic has posed new challenges to cardiologists around the world. In this video, Ian Rowlandson, Chief Scientist of Diagnostic Cardiology at GE Healthcare, asks Dr. Nicola Cosentino of the Monzino Cardiology Center in Milan, Italy about diagnosing ST-elevation acute myocardial infarction (STEMI) in COVID-19 patients. Dr. Cosentino views STEMI as a critically time-dependent emergency, as untreated cardiac issues in COVID-19 patients can lead to complications. Once ST-segment elevation is confirmed in a patient, Dr. Cosentino follows specific procedures that help maximize the safety of the patient and his colleagues and help prevent the spread of COVID-19.

  • The complicating factors of diagnosing STEMI in COVID-19 patients

    A variety of cardiological complications can drastically affect patient outcomes during the COVID-19 pandemic. In this video, Dr. Nicola Cosentino of the Monzino Cardiology Center in Milan, Italy and Ian Rowlandson, Chief Scientist of Diagnostic Cardiology at GE Healthcare, discuss how factors such as rising troponin levels and ST-segment elevation are involved in diagnosing STEMI and myocarditis in patients with COVID-19. Dr. Cosentino also describes the procedures his facility currently employs in the event of acute heart failure, cardiogenic shock, or life-threatening arrhythmias.

  • COVID-19 and Myocarditis

    One cardiological question that has emerged during the pandemic is whether the SARS-CoV-2 virus can cause myocarditis. In this video, Dr. Nicola Cosentino of the Monzino Cardiology Center in Milan, Italy and Ian Rowlandson, Chief Scientist of Diagnostic Cardiology at GE Healthcare, discuss the potential relationship between myocarditis and COVID-19. Dr. Cosentino describes some of the challenges clinicians have faced when diagnosing myocarditis during the COVID-19 pandemic, particularly around the use of diagnostic tools such as MRI. He also offers advice on the role of ECG, echo, and troponin analysis in determining whether a patient is experiencing myocarditis.

  • Assessing Prolonged QT in COVID-19 Patients

    In this video, Dr. Nicola Cosentino of the Monzino Cardiology Center in Milan, Italy and Ian Rowlandson, Chief Scientist of Diagnostic Cardiology at GE Healthcare, discuss the influence of QT interval on cardiac treatments and patient outcomes during the COVID-19 pandemic. Dr. Cosentino describes the potentially dangerous effects that can accompany prolonged QT intervals in patients suffering from COVID-19, including life-threatening arrhythmias. He also delineates the QT-corrected thresholds that his department uses to determine whether a patient’s ECG should be monitored regularly for corrected QT interval increases.

  • Cardiology and COVID-19: The New Normal

    COVID-19 has brought about a new normal for cardiologists, and for the world at large. In this video, Dr. Nicola Cosentino of the Monzino Cardiology Center in Milan, Italy and Ian Rowlandson, Chief Scientist of Diagnostic Cardiology at GE Healthcare, discuss what this new normal looks like and what Dr. Cosentino wishes he had known at the start of the COVID-19 pandemic in Italy. Dr. Cosentino describes how treatment options and procedures have evolved at the Monzino Cardiology Center since the pandemic began.

Cardiology Trends

JB01114IN

WIPRO GE HEALTHCARE PVT LTD
No. 4, Kadugodi Industrial Area,
Bangalore 560067,
Karnataka, India
CIN: U33111KA1990PTC01606